Renal insufficiency induced by cisplatin in rats is ameliorated by cyclosporin A

Toxicology

Volumn 114, Issue 1, 1996, Pages 11-17

  Campbell, Philip I ^a   Al Nasser, Ibrahim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Calcium; Cisplatin; Cyclosporin A; Kidney; Membrane potential; Mitochondrial; Nephrotoxicity

Indexed keywords

CISPLATIN; CYCLOSPORIN A; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CORTEX; KIDNEY FAILURE; MALE; MEMBRANE POTENTIAL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM; CISPLATIN; CREATININE; CYCLOSPORINS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; KIDNEY CORTEX; KIDNEY FAILURE, ACUTE; MALE; MEMBRANE POTENTIALS; MITOCHONDRIA; RATS; RATS, SPRAGUE-DAWLEY; UREA;

ANIMALIA;

EID: 0030589077     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(96)03411-7     Document Type: Article

References (26)

1. 2+-induced depolarisation of renal cortex mitochondria. Med. Sci. Res. 21, 647-649.
2. Al-Nasser, I.A. and Campbell, P.I. (1993b) CyclosporinA inhibition of phosphate induced calcium release from rat kidney cortex mitochondria. Med. Sci. Res. 21, 777-779.
3. Al-Nasser, I. and Crompton, M. (1986) The reversible permeabilization of rat liver mitochondria. Biochem. J. 239, 19-29.
4. 2+ by liver mitochondria. J. Biol. Chem. 259, 1279-1287.
5. 2+-dependent damage of isolated rat liver and renal cortex mitochondria. Comp. Biochem. Physiol. 111(2), 221-225.
6. Crompton, M. (1985) The calcium carriers of mitochondria. In: A.N. Matonosi (Ed), The Enzymes of Biological Membranes, Plenum, New York, pp. 249-286.
7. 2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem. J. 245, 915-918.
8. 2+ overload. Eur. J. Biochem. 178, 448-450.
9. Crompton, M., McGuiness, O. and Nazareth, W. (1992) The involvement of cyclosporin binding proteins in regulating and uncoupling mitochondrial energy transduction. Biochem. Biophys. Acta 110(2), 214-217.
10. Dobyan, D.C., Levi, J., Jacobs, C., Kosek, J. and Weiner, M.W. (1980) Mechanisms of cisplatin nephrotoxicity: II. morphological observations. J. Pharmacol. Exp. Ther. 213, 551-556.
11. Gordon, J.A. and Gattone II, V.H. (1988) Mitochondrial alterations in cisplatin-induced acute renal failure. Am. J. Physiol. 250, F991-F998.
12. Griffiths, E.J. and Halestrap, A.P. (1991) Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Biochem. J. 274, 611-614.
13. 2+. Biochem. J. 290, 489-495.
14. Kamo, N., Muratsugo, M., Ruyi, H. and Kobatake, J. (1979) Membrane potential of mitochondria measured with an electrode sensitive to tetraphenylphosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Memb. Biol. 48, 105-121.
15. Kroger, A. and Klingenberg, M. (1966) A modified Biuret method for the determination of protein. Biochem. Z. 344, 317-338.
16. Madias, N.E. and Harrington, J.T. (1978) Platinum nephrotoxicity. Am. J. Med. 68, 307-314.
17. McCormack, J.G., Halestrap, A.P. and Denton. R.M. (1990) Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 70, 391-425.
18. Nazareth, W., Yafei, M. and Crompton, M. (1991) Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A. J. Mol. Cell. Cardiol. 23, 1351-1354.
19. 2+ plus prooxidants. Biochem. Pharmacol. 44, 1795-1801.
20. Rosenberg, B., Van Camp, L., Trosko, J.H. and Mansour, V.H. (1969) Platinum compounds: A new class of potent anti-tumor agents. Nature 222, 385-386.
21. 2+ release to cyclosporin A and related compounds. Biochem. Pharmacol. 45, 641-646.
22. Singh, G. (1989) A possible cellular mechanism of cisplatin-induced nephrotoxicity. Toxicology 58, 71-80.
23. Stein, J., Lifschitz, M. and Barnes, L. (1978) Current concepts on the nephrotoxicity of acute renal failure. Am. J. Physiol. 243, F171-F181.
24. 2+ release and pore formation by prooxidants. Biochem. Pharmacol. 47, 2147-2156.
25. Williams, S.D. and Einhorn, L.H. (1982) Cisplatinum in the treatment of testicular and other cancers. Adv. Intern. Med. 27, 531-545.
26. Zhang, J.G. and Lindup, W.E. (1994) Cisplatin nephrotoxicity: Decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem. Pharmacol. 47, 1127-1135.